Sarasin to merge away Digital Opportunities fund

Investor focus shifted

clock • 2 min read

Sarasin has decided to merge its Digital Opportunities fund with the Sarasin Responsible Global Equity fund as it does not “foresee a scenario” that would “bring about an upturn in the fund’s performance and long-term viability”.

In a letter seen by Investment Week, Sarasin told investors that the markets the digital fund invests in "have changed significantly since it launched". "The markets appear to favour a small number of ‘mega-cap' technology companies over the small and medium-sized companies such as those in which the fund invests," the letter stated. "Sarasin doesn't foresee a scenario, within the next two to three years at least, which would see investors focus again on the small and mid-sized digitalisation companies within the fund's investment strategy." The Digital Opportunities fund, which is co...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot